Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deals Of The Week: Exelixis/BMS, Valeant/Dow, Novartis Option Fund/Ascent

Executive Summary

Each week, "The Pink Sheet" presents commentary on some of the week's most interesting business deals, contributed by the editors of the IN VIVO blog. Visit the blog at 1http://invivoblog.blogspot.com/.
Advertisement

Related Content

Drug Ads Should Take A Long View, DDMAC Says In Citing Time-To-Onset Claims
Phase III Data With Scar Therapy Still Distant, Renovo Draws A Suitor
Dermatology Space Waits For Skinny On Stiefel Buyout
Venture Capital Firms Looking For Plan B
Venture Capital Firms Looking For Plan B
Biopharma in 2008: What a Difference an Economic Crisis Makes
New Funding Source For Cash-Strapped BioPharma
Corporate VC Adds a Business Development Flavor
Exelixis: Bartering for Growth
Exelixis: Bartering for Growth
Advertisement
UsernamePublicRestriction

Register

PS050439

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel